Key Takeaway: The article discusses a mono-center observational study on the CompuFlo device, which measures epidural pressure in real-time. This innovative approach could enhance clinical practices and improve patient outcomes. Milestone Scientific reports a positive revenue growth and strengthening of its board, indicating a strategic focus on future growth.
Price reaction · baseline $0.4401 (2025-08-01T16:37:00.000Z) · hit during market hours · 1 other MLSS headline(s) in the window, move may be shared
day 0 close · peak
-2.1%
Market Sentiment Analysis
Full Press Release Details
• SHARE
Read the full publication here.
LATEST NEWS
• Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9%… July 1, 2026
• Milestone Scientific Strengthens Board to Support Next Phase of Growth June 25, 2026
• Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance… May 27, 2026
Frequently Asked Questions
What is the CompuFlo device used for?
The CompuFlo device is used for real-time measurement of epidural pressure.
What type of study was conducted on the CompuFlo device?
A mono-center observational study was conducted to evaluate the device.
What are the benefits of the CompuFlo device?
The device may enhance clinical practices and improve patient outcomes.
What recent developments has Milestone Scientific reported?
Milestone Scientific reported a preliminary revenue growth of 9% for 1H 2026.